THE ON DECK NEWS

THE ON DECK NEWS DAILY

Menu
  • Terms and Conditions
  • Privacy Policy
Menu

Moderna says the FDA wants extra time to evaluate its teenage vaccine

Posted on October 31, 2021 by

Moderna said it would take more time for the Food and Drug Administration to complete its assessment of the biotech company’s Covid-19 vaccine for children ages 12-17.

The agency is specifically studying the risk of developing myocarditis in children, Moderna said in a statement on Sunday, and the review may not complete until January 2022. Myocarditis is the inflammation of the heart muscle.

“The company is determined to work closely with the FDA in support of its review and is grateful to the FDA for their diligence,” said Moderna.

Moderna also said it will delay filing an emergency approval application for a smaller dose of the vaccine for younger children ages 6-11 while the FDA completes its review.

Moderna said on May 25 that its Covid vaccine was 100% effective in a study of 12 to 17 year olds. The company then applied in June to expand the emergency use of its vaccine to teenagers.

Subscribe to CNBC on YouTube.

Recent Posts

  • A Review of the Quinear Air Compression Leg Massager
  • Cloud Massage Shiatsu Foot Massager Machine Reviews
  • How to Activate Your New Credit Card
  • Ways to Pay With Mastercard
  • The Benefits of an Amex Platinum Card

Recent Comments

    Archives

    • June 2022
    • May 2022
    • April 2022
    • March 2022
    • February 2022
    • January 2022
    • December 2021
    • November 2021
    • October 2021
    • September 2021
    • August 2021
    • July 2021
    • June 2021
    • May 2021
    • April 2021
    • March 2021
    • February 2021
    • January 2021

    Categories

    • Business
    • Finance
    • Health
    • Life
    • News
    • Shopping
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    ©2022 THE ON DECK NEWS | Design: Newspaperly WordPress Theme